Clicky

LivaNova PLC(LIA)

Description: LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.


Keywords: Medical Equipment Healthcare Providers Neurotechnology Cardiac Surgery Neuromodulation Therapeutic Solutions Cardiopulmonary Bypass Drug Resistant Epilepsy Autotransfusion Cardiopulmonary Products Livanova Perfusionist

Home Page: www.livanova.com

20 Eastbourne Terrace
London, W2 6LG
United Kingdom
Phone: 44 20 3325 0660


Officers

Name Title
Mr. Alex Shvartsburg C.M.A. Chief Financial Officer
Mr. Michael D. Hutchinson Senior VP, Chief Legal Officer & Company Secretary
Mr. Vladimir A. Makatsaria CEO & Director
Ms. Lindsey Little Senior Director of Investor Relations
Deanna Wilke Vice President of Corporate Communications
Mr. Matthew Joseph Dodds III Senior Vice President of Corporate Development & IT
Mr. Paul R. Buckman President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement
Ms. Stephanie Bolton President of Global Epilepsy
Ahmet Tezel Ph.D. Chief Innovation Officer
Mr. Franco Poletti President of Cardiopulmonary Business Unit

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 20.9205
Trailing PE: 115.122
Price-to-Book MRQ: 2.0709
Price-to-Sales TTM: 2.1008
IPO Date:
Fiscal Year End: December
Full Time Employees: 2900
Back to stocks